Vanguard Group Inc Roivant Sciences Ltd. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Vanguard Group Inc holds 41,683,055 shares of ROIV stock, worth $498 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
41,683,055
Previous 8,191,824
408.84%
Holding current value
$498 Million
Previous $86.6 Million
455.54%
% of portfolio
0.01%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ROIV
# of Institutions
319Shares Held
524MCall Options Held
1.3MPut Options Held
1.09M-
Viking Global Investors LP69.2MShares$826 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$797 Million72.99% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$788 Million6.27% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$423 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$350 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.42B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...